CARLA ROBERTS: Open Payments
NPI 1477950830 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,879 in 123 payments from 21 companies in 2025. Trend: 2023 $642 · 2024 $500 · 2025 $2,879
Food & beverage: $2,780Education: $99
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $592 |
| Regeneron Healthcare Solutions, Inc. | 9 | $303 |
| GlaxoSmithKline, LLC. | 14 | $221 |
| Amgen Inc. | 14 | $219 |
| Genentech USA, Inc. | 10 | $213 |
| ARS Pharmaceuticals Operations, Inc. | 11 | $204 |
| Novartis Pharmaceuticals Corporation | 9 | $187 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $186 |
| Blueprint Medicines Corporation | 5 | $145 |
| CSL Behring | 5 | $143 |
Products named: DUPIXENT, TEZSPIRE, Xolair, AIRSUPRA, FASENRA, NEFFY, NUCALA, AYVAKIT.
Industry payments across AL — which companies pay providers there.
